Free Trial
LON:CNSL

Cambridge Nutritional Sciences Interim Earnings Results & Report

GBX 1.48 -0.07 (-4.26%)
As of 11:14 AM Eastern

Cambridge Nutritional Sciences reported Interim earnings on November 10, 2026. The company reported EPS of -GBX 0.30, while revenue was £2.36 million.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

Cambridge Nutritional Sciences EPS Results

Actual EPS
-GBX 0.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cambridge Nutritional Sciences Revenue Results

Actual Revenue
£2.36 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Cambridge Nutritional Sciences Interim Earnings FAQ

Cambridge Nutritional Sciences (LON:CNSL) reported earnings of -GBX 0.30 per share for Interim. The report was announced on Tuesday, November 10, 2026.

Cambridge Nutritional Sciences reported revenue of £2.36 million for Interim.

Cambridge Nutritional Sciences Earnings Headlines

I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Cambridge Nutritional Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cambridge Nutritional Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cambridge Nutritional Sciences and other key companies, straight to your email.

About Cambridge Nutritional Sciences

Cambridge Nutritional Sciences (LON:CNSL) (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

View Cambridge Nutritional Sciences Profile